Recombinant Human uPAR Protein

Carrier Free

Catalog # Availability Size / Price Qty
807-UK-100/CF

With Carrier

Catalog # Availability Size / Price Qty
807-UK-100
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (8)
FAQs
Supplemental Products
Reviews (1)

Recombinant Human uPAR Protein Summary

Product Specifications

Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human uPAR at 5 µg/mL (100 µL/well) can bind Recombinant Human u‑Plasminogen Activator (uPA)/Urokinase (Catalog # 1310-SE) with a linear range of 0.3-20 ng/mL.
Source
Mouse myeloma cell line, NS0-derived human uPAR protein
Leu23-Arg303, with a C-terminal 6-His tag
Accession #
N-terminal Sequence
Analysis
Leu23
Predicted Molecular Mass
31 kDa
SDS-PAGE
40-55 kDa, reducing conditions

Product Datasheets

You must select a language.

x

807-UK (with carrier)

You must select a language.

x

807-UK/CF (carrier free)

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

807-UK

Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Reconstitution Reconstitute at 10 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

807-UK/CF

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 100 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: uPAR

The urokinase-type Plasminogen Activator (uPA) is one of two activators that converts the extracellular zymogen plasminogen to plasmin, a serine protease that is involved in a variety of normal and pathological processes that require cell migration and/or tissue destruction. uPA is synthesized and released from cells as a
single-chain (sc) pro-enzyme with limited enzymatic activity and is converted to an active two-chain (tc) disulfide-linked active enzyme by plasmin and other specific proteinases. Both the scuPA and tcuPA bind with high-affinity to the cell surface via the glycosyl phosphatidylinositol-linked receptor uPAR which serves to localize the uPA proteolytic activity. The enzymatic activity of scuPA has also been shown to be enhanced by binding to uPAR. Independent of their proteolytic activity, the uPA/uPAR interaction also initiates signal transduction responses resulting in activation of protein tyrosine kinases, gene expression, cell adhesion, and chemotaxis. uPAR can interact with integrins to suppress normal integrin adhesive function and promote adhesion to vitronectin through a high affinity vitronectin binding site on uPAR. uPAR cDNA encodes a 335 amino acid (aa) residue precursor protein with a 22 aa residue signal peptide, five potential N-linked glycosylation sites and a
C-terminal GPI-anchor site. An alternate spliced variant of uPAR encoding a secreted soluble form of uPAR also exists. Human and mouse uPAR share approximately 60% aa sequence identity and the receptor-ligand interaction is strictly species-specific.

References
  1. Dear, A.E. and R.L. Medcalf, Eur. J. Biochemistry (1998) 252:185.
Long Name
Urokinase-type Plasminogen Activator Receptor
Entrez Gene IDs
5329 (Human); 18793 (Mouse); 102139334 (Cynomolgus Monkey)
Alternate Names
CD87 antigen; CD87; Monocyte activation antigen Mo3; plasminogen activator, urokinase receptor; PLAUR; uPAR; U-PAR; UPARurokinase plasminogen activator surface receptor; u-plasminogen activator receptor form 2; URKRMO3

Citations for Recombinant Human uPAR Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

8 Citations: Showing 1 - 8
Filter your results:

Filter by:

  1. Simultaneous stabilization of actin cytoskeleton in multiple nephron-specific cells protects the kidney from diverse injury
    Authors: K Mukherjee, C Gu, A Collins, M Mettlen, B Samelko, MM Altintas, YR Sudhini, X Wang, R Bouley, D Brown, BP Pedro, SL Bane, V Gupta, PT Brinkkoett, H Hagmann, J Reiser, S Sever
    Nature Communications, 2022-05-03;13(1):2422.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  2. Deiodinase-3 is a thyrostat to regulate podocyte homeostasis
    Authors: S Agarwal, KH Koh, NJ Tardi, C Chen, RR Dande, JP WerneckdeC, YR Sudhini, C Luongo, D Salvatore, B Samelko, MM Altintas, S Mangos, A Bianco, J Reiser
    EBioMedicine, 2021-10-11;72(0):103617.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Surface Plasmon Resonance (SPR
  3. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis
    Authors: JN An, JS Hyeon, Y Jung, YW Choi, JH Kim, SH Yang, S Oh, S Kwon, SH Lee, JH Cho, SH Park, H Ha, DK Kim, JP Lee, GS Hwang
    Sci Rep, 2019-10-11;9(1):14707.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  4. uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
    Authors: C Wei, J Li, BD Adair, K Zhu, J Cai, M Merchant, B Samelko, Z Liao, KH Koh, NJ Tardi, RR Dande, S Liu, J Ma, S DiBartolo, S Hägele, V Peev, SS Hayek, DJ Cimbaluk, M Tracy, JB Klein, S Sever, SJ Shattil, MA Arnaout, J Reiser
    J. Clin. Invest., 2019-04-02;0(0):.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: SDS-Page
  5. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
    Authors: Huang J, Liu G, Zhang Y, Cui Z, Wang F, Liu X, Chu R, Zhao M
    BMC Med, 2014-05-20;12(0):81.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  6. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
    Authors: Zhuang T, Chelluboina B, Ponnala S, Velpula K, Rehman A, Chetty C, Zakharian E, Rao J, Veeravalli K
    BMC Cancer, 2013-12-11;13(0):590.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  7. Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels.
    Authors: Portelli M, Siedlinski M, Stewart C, Postma D, Nieuwenhuis M, Vonk J, Nurnberg P, Altmuller J, Moffatt M, Wardlaw A, Parker S, Connolly M, Koppelman G, Sayers I
    FASEB J, 2013-11-18;28(2):923-34.
    Applications: Bioassay
  8. Development and validation of sandwich ELISA microarrays with minimal assay interference.
    Authors: Gonzalez RM, Seurynck-Servoss SL, Crowley SA
    J. Proteome Res., 2008-04-19;7(6):2406-14.
    Applications: ELISA (Standard)

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs
Loading...

Reviews for Recombinant Human uPAR Protein

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Recombinant Human uPAR Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Recombinant Human uPAR Protein
By Anonymous on 02/25/2024
Application: We employed a co-culture system to assess the impact of Recombinant uPAR on stimulating the functional transformation of fibroblasts and macrophages. We hypothesized that uPAR primarily drove these effects, and the outcomes were remarkably positive.